6 unchanged sentences
(incorporated by reference to Exhibit 3.2 to our Current Report on Form 8-K filed October 6, 2020).
−Removed: Second Amended and Restated Non-Employee Director Compensation Policy, effective as of June 15, 2022 .
+Added: Letters to Holders of Series B Warrants to Purchase Shares of Common Stock (incorporated by reference to Exhibit 10.1 to our Current Report on Form 8K filed September 2, 2022).
Certification of Chief Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
4 unchanged sentences
Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
−Removed: Interactive Data File (Form 10-Q for the Quarterly Period ended June 30, 2022 filed in XBRL).
+Added: Interactive Data File (Form 10-Q for the Quarterly Period ended September 30, 2022 filed in XBRL).
The financial information contained in the XBRL-related documents is "unaudited"
6 unchanged sentences
IMMUNOME, INC.
−Removed: August 5, 2022
+Added: November 14, 2022
/s/ Purnanand D.
1 unchanged sentence
(Principal Executive Officer)
−Removed: August 5, 2022
+Added: November 14, 2022
/s/ Corleen M.
2 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.